Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma

Overview of attention for article published in Biologics: Targets & Therapy, January 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Use of reslizumab to treat moderate to severe eosinophilic asthma

Grant US-10577414-B2

United States of America